Patient Guide: Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 160 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03298451
Status: ACTIVE_NOT_RECRUITING
Condition: Hepatocellular Carcinoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 160 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Los Angeles, California
  • Orange, California
  • San Francisco, California
  • • And 157 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily